{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:35:37Z","timestamp":1788446137183,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Human metapneumovirus (hMPV) can cause severe respiratory illnesses such as bronchitis, bronchiolitis, and pneumonia, particularly in young children, older adults, and individuals with weakened immune systems. This study aimed to assess hMPV circulation patterns, including seasonal and demographic distribution, track genetic evolution and mutations in surface proteins, and explore associations with clinical severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From early 2023 to November 2025, Bulgaria\u2019s National Reference Laboratory tested nasopharyngeal samples from 6,958 patients with respiratory symptoms using an in-house multiplex real-time PCR method that detected 11 viruses. Positive hMPV samples were sequenced and analyzed phylogenetically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A study conducted 3 years after the COVID-19 pandemic found that 1.4% (97 patients) tested positive for hMPV, with most being mono-infected (85.6%) and others co-infected, primarily with rhinovirus and adenovirus. The infection rate was highest in children under 5 (2.8%), especially infants and toddlers (2.2%), compared to 0.4% in those over 65 (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). Common symptoms in 56% of hMPV-positive patients included cough (50%), fever (38%), and rhinitis (21.2%). Among 94 patients with respiratory involvement, 34% had upper respiratory tract infections (URTs), and 55% had lower respiratory tract infections (LRTs), with bronchiolitis (46%) and pneumonia (30.7%) being common. Hospitalized patients had a 19% rate of severe acute respiratory infection (SARI), higher than the 7.3% for other viruses. Sequencing revealed genotypes A and B in similar proportions, with subclade B2 being the most common at 41.3%. However, in 2025, subclade A2b2 represented 52% of the samples. The A2b2 subclade in children under 5 showed a higher incidence of lower respiratory complications (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05), while genotype B was linked to an increased risk of SARI at higher viral loads (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings confirm that hMPV is a significant respiratory pathogen for young children, showing substantial genetic diversity in Bulgaria, with lineage A2b2 becoming more prevalent in 2025. Host age and viral genetics may influence disease presentation. These results highlight the clinical burden of hMPV and emphasize the need for preventive strategies, including vaccine development for high-risk children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1834413","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:55:44Z","timestamp":1778651744000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic and epidemiological characteristics of the spread of human metapneumovirus in Bulgaria, 2023\u20132025"],"prefix":"10.3389","volume":"14","author":[{"given":"I.","family":"Trifonova","sequence":"first","affiliation":[{"name":"Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory \u201cInfluenza and ARD\u201d","place":["Sofia, Bulgaria"]},{"name":"Center of Competence \u201cImmunoPathogen\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Korsun","sequence":"additional","affiliation":[{"name":"Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory \u201cInfluenza and ARD\u201d","place":["Sofia, Bulgaria"]},{"name":"Center of Competence \u201cImmunoPathogen\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pavlova","sequence":"additional","affiliation":[{"name":"Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory \u201cInfluenza and ARD\u201d","place":["Sofia, Bulgaria"]},{"name":"Center of Competence \u201cImmunoPathogen\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zh.","family":"Getsova","sequence":"additional","affiliation":[{"name":"Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory \u201cInfluenza and ARD\u201d","place":["Sofia, Bulgaria"]},{"name":"Center of Competence \u201cImmunoPathogen\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rukmanski","sequence":"additional","affiliation":[{"name":"Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory \u201cInfluenza and ARD\u201d","place":["Sofia, Bulgaria"]},{"name":"Center of Competence \u201cImmunoPathogen\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Valkov","sequence":"additional","affiliation":[{"name":"Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia","place":["Sofia, Bulgaria"]},{"name":"Affiliate \u201cProf. Dr. Ivan Mitev\u201d Vratsa, Medical University of Sofia","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Velikov","sequence":"additional","affiliation":[{"name":"Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory \u201cInfluenza and ARD\u201d","place":["Sofia, Bulgaria"]},{"name":"Center of Competence \u201cImmunoPathogen\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia","place":["Sofia, Bulgaria"]},{"name":"Affiliate \u201cProf. Dr. Ivan Mitev\u201d Vratsa, Medical University of Sofia","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dakov","sequence":"additional","affiliation":[{"name":"University Hospital \u201cLozenetz\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia","place":["Sofia, Bulgaria"]},{"name":"Affiliate \u201cProf. Dr. Ivan Mitev\u201d Vratsa, Medical University of Sofia","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Uzunova","sequence":"additional","affiliation":[{"name":"Infectious Disease Hospital \u201cProf. Ivan Kirov\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Christova","sequence":"additional","affiliation":[{"name":"Department of Virology, National Centre of Infectious and Parasitic Diseases, National Laboratory \u201cInfluenza and ARD\u201d","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jmii.2024.12.002","article-title":"Post-pandemic epidemiological trends of respiratory infectious diseases in Taiwan: a retrospective analysis","volume":"58","author":"Liu","year":"2025","journal-title":"J Microbiol Immunol Infect"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/v15051160","article-title":"Epidemiology of respiratory infections during the COVID-19 pandemic","volume":"15","author":"Principi","year":"2023","journal-title":"Viruses"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12985-025-02782-y","article-title":"Human metapneumovirus (hMPV) in 2025: emerging trends and insights from community and hospital-based respiratory panel analyses-a comprehensive review","volume":"22","author":"Mohammadi","year":"2025","journal-title":"Virol J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"101563","DOI":"10.1016\/j.nmni.2025.101563","article-title":"The surge of human metapneumovirus (hMPV) cases in China and global implications","volume":"63","author":"Al-Tawfiq","year":"2025","journal-title":"New Microbes New Infect"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1616548","DOI":"10.3389\/fcimb.2025.1616548","article-title":"Clinical characterisation of human metapneumovirus infection in 525 patients with respiratory tract infections in Jilin province","volume":"15","author":"Liu","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e00284-25","DOI":"10.1128\/jvi.00284-25","article-title":"Human metapneumovirus: understanding the molecular mechanisms and pathology of infection","volume":"99","author":"Heim","year":"2025","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1042\/CS20160011","article-title":"Role of human metapneumovirus and respiratory syncytial virus in asthma exacerbations: where are we now?","volume":"131","author":"Rudd","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/microorganisms13071508","article-title":"hMPV outbreaks: worldwide implications of a re-emerging respiratory pathogen","volume":"13","author":"Lianou","year":"2025","journal-title":"Microorganisms"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.meegid.2011.01.016","article-title":"Genetic variability of human metapneumovirus amongst an all ages population in Cambodia between 2007 and 2009","volume":"15","author":"Arnott","year":"2013","journal-title":"Infect Genet Evol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jcv.2016.05.015","article-title":"Human metapneumovirus in patients hospitalized with acute respiratory infections: a meta-analysis","volume":"81","author":"Lefebvre","year":"2016","journal-title":"J Clin Virol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7627","DOI":"10.1038\/s41467-023-43434-5","article-title":"Structure of the N-RNA\/P interface indicates mode of L\/P recruitment to the nucleocapsid of human metapneumovirus","volume":"14","author":"Whitehead","year":"2023","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/microorganisms8091280","article-title":"Recent molecular evolution of human metapneumovirus (HMPV): subdivision of HMPV A2b strains","volume":"8","author":"Nao","year":"2020","journal-title":"Microorganisms"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"593594","DOI":"10.1101\/2024.05.10.593594","article-title":"Human metapneumovirus SH protein promotes JAK1 degradation to impair host IL-6 signaling","author":"Brynes","year":"2024","journal-title":"bioRxiv"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"8224","DOI":"10.1128\/JVI.02584-07","article-title":"Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity","volume":"82","author":"Bao","year":"2008","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/v13030499","article-title":"An amplicon-based approach for the whole-genome sequencing of human metapneumovirus","volume":"13","author":"Tulloch","year":"2021","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12985-024-02327-9","article-title":"Epidemiology and diagnosis technologies of human metapneumovirus in China: a mini review","volume":"21","author":"Feng","year":"2024","journal-title":"Virol J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000516821","article-title":"The prevalence and genetic characterization of human metapneumovirus in Bulgaria, 2016-2019","volume":"64","author":"Korsun","year":"2021","journal-title":"Intervirology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3390\/biomedicines12102210","article-title":"Bacterial and viral co-infections in COVID-19 patients: etiology and clinical impact","volume":"12","author":"Trifonova","year":"2024","journal-title":"Biomedicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1743-422X-6-138","article-title":"Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years","volume":"6","author":"Yang","year":"2009","journal-title":"Virol J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"104590","DOI":"10.1016\/j.jcv.2020.104590","article-title":"Insights into immune evasion of human metapneumovirus: novel 180- and 111-nucleotide duplications within viral G gene throughout 2014-2017 seasons in Barcelona, Spain","volume":"132","author":"Pi\u00f1ana","year":"2020","journal-title":"J Clin Virol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/vaccines13010017","article-title":"SARS-CoV-2 evolution: implications for diagnosis, treatment, vaccine effectiveness and development","volume":"13","author":"Angius","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"100667","DOI":"10.1016\/j.lansea.2025.100667","article-title":"Epidemiology of human metapneumovirus (HMPV) in India: a cross-sectional study","volume":"41","author":"Abdulkader","year":"2025","journal-title":"Lancet Reg Health - Southeast Asia"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"Doc78","DOI":"10.3205\/dgkh000607","article-title":"Human metapneumovirus: an emerging public health threat and harbinger of a new pandemic","volume":"20","author":"Sara\u00e7","year":"2025","journal-title":"GMS Hyg Infect Control"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.3346\/jkms.2024.39.e171","article-title":"Epidemiology of respiratory viruses in Korean children before and after the COVID-19 pandemic: a prospective study from National Surveillance System","volume":"39","author":"Cho","year":"2024","journal-title":"J Korean Med Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e70114","DOI":"10.1111\/irv.70114","article-title":"Epidemiological shifts in children respiratory pathogens in Shenzhen, China: a comparative analysis before and after the relaxation of COVID-19 non-pharmaceutical interventions","volume":"19","author":"Wang","year":"2025","journal-title":"Influenza Other Respir Viruses"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s44162-025-00079-w","article-title":"Rising global threat of human metapneumovirus (hMPV in 2024\/2025): pathogenesis, immune dynamics, vulnerabilities in immunocompromised individuals, and lessons from past pandemics","volume":"4","author":"Adedokun","year":"2025","journal-title":"J Rare Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00705-024-06147-8","article-title":"Epidemiology of human metapneumovirus in Taiwan from 2013 to 2023","volume":"169","author":"Yang","year":"2024","journal-title":"Arch Virol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"103480","DOI":"10.1016\/j.eclinm.2025.103480","article-title":"The prevalence and role of human metapneumovirus in respiratory tract infections: a systematic review and meta-analysis of global data","volume":"88","author":"Khales","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1086\/652782","article-title":"Population-based incidence of human metapneumovirus infection among hospitalized children","volume":"201","author":"Williams","year":"2010","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.virs.2022.08.007","article-title":"Clinical characteristics and molecular epidemiology of human metapneumovirus in children with acute lower respiratory tract infections in China, 2017 to 2019: a multicentre prospective observational study","volume":"37","author":"Zhao","year":"2022","journal-title":"Virol Sin"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"631.e1","DOI":"10.1016\/j.cmi.2020.05.042","article-title":"Dynamics and predisposition of respiratory viral co-infections in children and adults","volume":"27","author":"Mandelia","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12887-025-06101-w","article-title":"Human metapneumovirus in children with acute lower respiratory infections: effects on clinical and disease severity","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Pediatr"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/v17101338","article-title":"Molecular epidemiology of human metapneumovirus infections in children from San Luis Potos\u00ed-Mexico","volume":"17","author":"Mart\u00ednez-Marrero","year":"2025","journal-title":"Viruses"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/v14051058","article-title":"Global extension and predominance of human metapneumovirus A2 genotype with partial G gene duplication","volume":"14","author":"Mu\u00f1oz-Escalante","year":"2022","journal-title":"Viruses"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1186\/s12879-025-12080-1","article-title":"Molecular epidemiology and genetic diversity of human metapneumovirus among hospitalized children in Saudi Arabia during the COVID-19 era","volume":"25","author":"Almuqrin","year":"2025","journal-title":"BMC Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41392-025-02377-7","article-title":"Epidemiological and phylogenetic characteristics of human metapneumovirus in Beijing, China, 2014-2024","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/pathogens9020135","article-title":"Engineering of live chimeric vaccines against human metapneumovirus","volume":"9","author":"Ogonczyk Makowska","year":"2020","journal-title":"Pathogens."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/pathogens9020109","article-title":"Human metapneumovirus: a largely unrecognized threat to human health","volume":"9","author":"Russell","year":"2020","journal-title":"Pathogens"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1128\/AAC.00793-07","article-title":"Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus","volume":"52","author":"Deffrasnes","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e1005859","DOI":"10.1371\/journal.ppat.1005859","article-title":"Engineering, structure and immunogenicity of the human metapneumovirus F protein in the postfusion conformation","volume":"12","author":"M\u00e1s","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1099\/vir.0.030049-0","article-title":"Effects of N-linked glycosylation of the fusion protein on replication of human metapneumovirus in vitro and in mouse lungs","volume":"92","author":"Zhang","year":"2011","journal-title":"J Gen Virol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e0072322","DOI":"10.1128\/jvi.00723-22","article-title":"Evidence against the human metapneumovirus G, SH, and M2-2 proteins as bona fide interferon antagonists","volume":"96","author":"Groen","year":"2022","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1159\/000448374","article-title":"Molecular epidemiology of human metapneumovirus in Riyadh Province, Saudi Arabia","volume":"26","author":"Amer","year":"2016","journal-title":"J Mol Microbiol Biotechnol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fmicb.2017.00402","article-title":"180-nucleotide duplication in the G gene of human metapneumovirus A2b subgroup strains circulating in Yokohama City, Japan, since 2014","volume":"8","author":"Saikusa","year":"2017","journal-title":"Front Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s11033-022-08092-8","article-title":"The emergence of human metapneumovirus G gene duplication in hospitalized patients with respiratory tract infection, India, 2016-2018","volume":"50","author":"Parida","year":"2023","journal-title":"Mol Biol Rep"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/1348-0421.12543","article-title":"A novel 111-nucleotide duplication in the G gene of human metapneumovirus","volume":"61","author":"Saikusa","year":"2017","journal-title":"Microbiol Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2214-109X(20)30393-4","article-title":"Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study","volume":"9","author":"Wang","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2014.03.1394","article-title":"Human metapneumovirus: review of an important respiratory pathogen","volume":"25","author":"Panda","year":"2014","journal-title":"Int J Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4103\/ijmr.IJMR_22_15","article-title":"Viruses causing severe acute respiratory infections (SARI) in children \u22645 years of age at a tertiary care hospital in Rajasthan, India","volume":"144","author":"Malhotra","year":"2016","journal-title":"Indian J Med Res"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1834413\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:55:45Z","timestamp":1778651745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1834413\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":49,"alternative-id":["10.3389\/fpubh.2026.1834413"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1834413","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1834413"}}